West Pharmaceutical Services | WST - Gewinn Vor Steuern

Aktienkurs
248.06
Täglich Wechseln
2.20 0.89%
Monatlich
1.85%
Jährlich
9.74%
Q1 Prognose
238.44




Gewinn Vor Steuern Veränderung Datum
Align Technology USD 176.6M 81.86M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dentsply International USD -230M 77M 2025-09
Haemonetics USD 59.97M 8.69M 2025-12
ICU Medical USD 70.3M 36.62M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
J&J USD 4.97B 2.53B 2025-12
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 73.18M 29.8M 2025-09
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -234K 3.37M 2024-06
Quidel USD -756.9M 527.3M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Rockwell Medical USD 343K 2.07M 2024-06
Solventum Corp USD 511M 149M 2025-09
STAAR Surgical USD 18.79M 44.7M 2025-09
Terumo JPY 45.38B 578M 2025-12
Utah Medical Products 418K 3K 2024-09
West Pharmaceutical Services USD 170.1M 8.1M 2025-09